Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1993-06-25
1995-07-11
Rizzo, Nicholas
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
540 94, 540114, C07J 1700, A61K 3158
Patent
active
054321697
ABSTRACT:
Cyclopentanperhydrophenantren-17.beta.-(3-furyl)-3-derivatives and pharmaceutical compositions containing same for the treatment of cardiovascular disorders such as heart failure and hypertension, are disclosed.
REFERENCES:
patent: 3436390 (1969-04-01), Lefebrune et al.
patent: 4259240 (1981-03-01), Wiesner et al.
Minato et al, Jour. Org. Chem pp. 377-379 (1966).
Humber et al, Steroids vol. 42 pp. 189-203 (1983).
Yoshii et al, Chem. Pharm. Bull vol. 24 3216-3219 (1976).
Steroids, Chapter 20 pp. 727-809 (1959).
Zurcher et al, Helvetica chimica Acta vol. 52 pp. 2449-2457 (1969).
Naidov et al, Jour of Pharmaceutical Science pp. 1391-1394 (1974).
Fritsch et al, Liebigr Ann. Chem vol. 727 pp. 110-120 (1969).
Templeton et al, J. Chem Soc pp. 251-256 (1983).
Vol. 88 et al, Gelvetica Chimica Acta vol. 16 pp. 108-116 (1959).
Bernardi Luigi
Ferrari Patrizia
Gobbini Mauro
Melloni Piero
Quadri Luisa
Rizzo Nicholas
Sigma-Tau Industrie Farmaceutiche Riunite S.p.A.
LandOfFree
Cyclopentanperhydrophenanthren-17.beta.-(3-furyl)-3-derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Cyclopentanperhydrophenanthren-17.beta.-(3-furyl)-3-derivatives , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Cyclopentanperhydrophenanthren-17.beta.-(3-furyl)-3-derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-503554